Skip to main content

Find Clinical Trials

Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,767 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors

NCT00003690

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

NCT00734188

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Hadassah Hebrew University Hospital Jerusalem, Israel

View Trial Details

Completed

Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

NCT00399113

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Hadassah Hebrew University Hospital Jerusalem, Israel

Chaim Sheba Medical Center Tel Litwinsky, Israel

View Trial Details

Completed

MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

NCT00094653

Conditions: Melanoma, Metastases, Neoplasm Metastasis, +14 more
Locations: Arizona Cancer Center Tucson, Arizona, United States

University Medical Center Tucson, Arizona, United States

City of Hope National Medical Center Duarte, California, United States

San Diego Cancer Center Encinitas, California, United States

View all 209 locations

View Trial Details

Completed

Phase II Trial of Allovectin-7® for Metastatic Melanoma

NCT00044356

Conditions: Malignant Melanoma, Melanoma, Metastatic Melanoma, +16 more
Locations: Arizona Cancer Center Tucson, Arizona, United States

University of Arkansas Cancer Research Center Little Rock, Arkansas, United States

Comprehensive Blood and Cancer Center Bakersfield, California, United States

University of California, San Francisco San Francisco, California, United States

View all 16 locations

View Trial Details

Completed

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00003646

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: Mayo Clinic Cancer Center Rochester, Minnesota, United States

Roswell Park Cancer Institute Buffalo, New York, United States

Physician Reliance Network, Inc. Dallas, Texas, United States

View Trial Details

Completed

Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer

NCT00004048

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +12 more
Locations: Garden State Cancer Center Belleville, New Jersey, United States

St. Joseph's Hospital and Medical Center Paterson, New Jersey, United States

View Trial Details

Completed

Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity

NCT00580060

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation

NCT00861107

Conditions: Breast Diseases, Breast Neoplasms, Colonic Diseases, +44 more
Locations: Immunovative Clinical Research, Inc Carlsbad, California, United States

View Trial Details

Completed

CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy

NCT00658437

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Haut Tumor Zentrum Charité Berlin, Germany

Dermatologisches Zentrum Elbe-Klinikum Buxtehude Buxtehude, Germany

Hautklinik Linden MH Hannover Hanover, Germany

Universitäts-Hautklinik Kiel Kiel, Germany

View Trial Details